[Therapy in IgA nephropathy--when and how to do it] (original) (raw)

Orvosi Hetilap, 2011

Abstract

IgA nephropathy is the most common primary glomerulonephritis worldwide. The clinical spectrum covers a wide range of features from minor urinary abnormalities (asymptomatic hematuria and mild proteinuria with normal renal function) to acute and chronic renal insufficiency. Ideally, the goal of treatment would be to correct any defects in IgA1 glycosylation and to modify mesangial deposition or removal of IgA1 deposits. There are only a few randomized controlled trials in IgA nephropathy; for this reason most treatment options are largely based on expert opinion. Authors discuss therapeutic options of different clinical pictures and the optimized renoprotective treatment of all IgA nephropathy patients.

Péter Degrell hasn't uploaded this paper.

Let Péter know you want this paper to be uploaded.

Ask for this paper to be uploaded.